Salarius Pharmaceuticals Inc Stock News
$1.52
8.98%
today
Nasdaq,
Dec 30, 10:00 pm CET
Salarius Pharmaceuticals Inc Stock News
Positive
InvestorPlace
●
5 months ago
Genomic therapeutic specialist Salarius Pharmaceuticals (NASDAQ: SLRX ) screamed higher Tuesday, with shares gaining 160% before paring back some of the gains to around 90%. Although no catalyst is apparent, the biotechnology firm revealed details about its at-the-market (ATM) offering recently.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
